Prophylactic Antibiotic Guidelines in Modern Interventional Radiology Practice

ABSTRACT

Modern interventional radiology practice is continuously evolving. Developments include increases in the number of central venous catheter placements and tumor treatments (uterine fibroid therapy, radio- and chemoembolization of liver tumor, percutaneous radiofrequency and cryoablation), and new procedures such as abdominal aortic aneurysm stent-graft repair, vertebroplasty, kyphoplasty, and varicose vein therapies. There have also been recent advancements in standard biliary and urinary drainage procedures, percutaneous gastrointestinal feeding tube placement, and transjugular intrahepatic portosystemic shunts. Prophylactic antibiotics have become the standard of care in many departments, with little clinical data to support its wide acceptance. The rise in antibiotic-resistant strains of organisms in all hospitals worldwide have forced every department to question the use of prophylactic antibiotics. The authors review the evidence behind use of prophylactic antibiotics in standard interventional radiology procedures, as well as in newer procedures that have only recently been incorporated into interventional radiology practice.

Antibiotic - prophylactic - interventional radiology

REFERENCES

• 1 Mulvey M R, Simor A E. Antimicrobial resistance in hospitals: how concerned should we be?.  CMAJ. 2009;  180(4) 408-415
• 2 Reddy P, Chadaga S, Noskin G A. Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review.  J Hosp Med. 2009;  4(6) E8-E15
• 3 Nicastri E, Leone S, Petrosillo N et al.. Decrease of methicillin resistant Staphylococcus aureus prevalence after introduction of a surgical antibiotic prophylaxis protocol in an Italian hospital.  New Microbiol. 2008;  31(4) 519-525
• 4 CDC Morbidity and Mortality Weekly Reports . Guidelines for the Prevention of Intravascular Catheter-Related Infections. Recommendations and Reports August 9, 2002/51 (RR10):1–26.  Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5110a1.htm Accessed October 11, 2010; 
• 5 Carlet J, Astagneau P, Brun-Buisson C French National Program for Prevention of Healthcare-Associated Infections and Antimicrobial Resistance et al. French National Program for Prevention of Healthcare-Associated Infections and Antimicrobial Resistance, 1992–2008: positive trends, but perseverance needed.  Infect Control Hosp Epidemiol. 2009;  30(8) 737-745
• 6 Kasatpibal N, Nørgaard M, Sørensen H T, Schønheyder H C, Jamulitrat S, Chongsuvivatwong V. Risk of surgical site infection and efficacy of antibiotic prophylaxis: a cohort study of appendectomy patients in Thailand.  BMC Infect Dis. 2006;  6 111
• 7 Yoshida S, Masuda H, Yokoyama M, Kobayashi T, Kawakami S, Kihara K. Absence of prophylactic antibiotics in minimum incision endoscopic urological surgery (MEUS) of adrenal and renal tumors.  Int J Urol. 2007;  14(5) 384-387
• 8 McDermott V G, Schuster M G, Smith T P. Antibiotic prophylaxis in vascular and interventional radiology.  AJR Am J Roentgenol. 1997;  169(1) 31-38
• 9 Spies J B, Rosen R J, Lebowitz A S. Antibiotic prophylaxis in vascular and interventional radiology: a rational approach.  Radiology. 1988;  166(2) 381-387
• 10 Wenzel R P. Preoperative antibiotic prophylaxis.  N Engl J Med. 1992;  326(5) 337-339
• 11 Classen D C, Evans R S, Pestotnik S L, Horn S D, Menlove R L, Burke J P. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection.  N Engl J Med. 1992;  326(5) 281-286
• 12 Sanchez-Manuel F J, Lozano-García J, Seco-Gil J L. Antibiotic prophylaxis for hernia repair.  Cochrane Database Syst Rev. 2007;  (3) CD003769
• 13 Di Leo A, Piffer S, Ricci F et al.. Surgical site infections in an Italian surgical ward: a prospective study.  Surg Infect (Larchmt). 2009;  10(6) 533-538 , epub ahead of print
• 14 Steinberg J P, Braun B I, Hellinger W C Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) Study Group et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors.  Ann Surg. 2009;  250(1) 10-16
• 15 Imai E, Ueda M, Kanao K, Miyaki K, Kubota T, Kitajima M. Surgical site infection surveillance after open gastrectomy and risk factors for surgical site infection.  J Infect Chemother. 2005;  11(3) 141-145
• 16 Miliani K, L'Hériteau F, Astagneau P. INCISO Network Study Group . Non-compliance with recommendations for the practice of antibiotic prophylaxis and risk of surgical site infection: results of a multilevel analysis from the INCISO Surveillance Network.  J Antimicrob Chemother. 2009;  64(6) 1307-1315
• 17 Openshaw K L, Picus D, Hicks M E, Darcy M D, Vesely T M, Picus J. Interventional radiologic placement of Hohn central venous catheters: results and complications in 100 consecutive patients.  J Vasc Interv Radiol. 1994;  5(1) 111-115
• 18 Openshaw K L, Picus D, Hicks M E, Darcy M D, Vesely T M, Picus J. Interventional radiologic placement of Hohn central venous catheters: results and complication in 100 consecutive patients.  J Vasc Interv Radiol. 1994;  5(1) 111-115
• 19 Biffi R, de Braud F, Orsi F et al.. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.  Ann Oncol. 1998;  9(7) 767-773
• 20 Ng F, Mastoroudes H, Paul E et al.. A comparison of Hickman line- and port-a-cath-associated complications in patients with solid tumours undergoing chemotherapy.  Clin Oncol. 2007;  19(7) 551-556
• 21 Cheong K, Perry D, Karapetis C, Koczwara B. High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours.  Intern Med J. 2004;  34(5) 234-238
• 22 Beddy P, Ryan J M. Antibiotic prophylaxis in interventional radiology—anything new?.  Tech Vasc Interv Radiol. 2006;  9(2) 69-76
• 23 Dravid V S, Gupta A, Zegel H G, Morales A V, Rabinowitz B, Freiman D B. Investigation of antibiotic prophylaxis usage for vascular and nonvascular interventional procedures.  J Vasc Interv Radiol. 1998;  9(3) 401-406
• 24 Whigham C J, Goodman C J, Fisher R G, Greenbaum M C, Thornby J I, Thomas J W. Infectious complications of 393 peripherally implantable venous access devices in HIV-positive and HIV-negative patients.  J Vasc Interv Radiol. 1999;  10(1) 71-77
• 25 Brokenshire E, Plank L D, Gillanders L K, McIlroy K, Parry B R. Adult total parenteral nutrition at Auckland City Hospital: a 6-year review.  N Z Med J. 2009;  122(1297) 17-24
• 26 Miller D L, O'Grady N P. Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology.  J Vasc Interv Radiol. 2003;  14(2 Pt 1) 133-136
• 27 van de Wetering M D, van Woensel J B. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients.  Cochrane Database Syst Rev. 2003;  (2) CD003295
• 28 Cicalini S, Palmieri F, Petrosillo N. Clinical review: new technologies for prevention of intravascular catheter-related infections.  Crit Care. 2004;  8(3) 157-162
• 29 Franz R W, Knapp E D. Transilluminated powered phlebectomy surgery for varicose veins: a review of 339 consecutive patients.  Ann Vasc Surg. 2009;  23(3) 303-309
• 30 Hamel-Desnos C, Gérard J L, Desnos P. Endovenous laser procedure in a clinic room: feasibility and side effects study of 1,700 cases.  Phlebology. 2009;  24(3) 125-130
• 31 van Groenendael L, van der Vliet J A, Flinkenflögel L, Roovers E A, van Sterkenburg S M, Reijnen M M. Treatment of recurrent varicose veins of the great saphenous vein by conventional surgery and endovenous laser ablation.  J Vasc Surg. 2009;  50(5) 1106-1113
• 32 Dunst K M, Huemer G M, Wayand W, Shamiyeh A. Diffuse phlegmonous phlebitis after endovenous laser treatment of the greater saphenous vein.  J Vasc Surg. 2006;  43(5) 1056-1058
• 33 Ramelet A A. Complications of ambulatory phlebectomy.  Dermatol Surg. 1997;  23(10) 947-954
• 34 Aremu M A, Mahendran B, Butcher W et al.. Prospective randomized controlled trial: conventional versus powered phlebectomy.  J Vasc Surg. 2004;  39(1) 88-94
• 35 McArthur N, Kasperk C, Baier M et al.. 1150 kyphoplasties over 7 years: indications, techniques, and intraoperative complications.  Orthopedics. 2009;  32(2) 90
• 36 Hirsch J. (2006) Vertebroplasty, Ground Rounds and other clinical conferences of the Massachusetts General Hospital, 2(10). Available at: http://www.painmanagementrounds.org/crus/painmgt_10_2005.pdf Accessed December 20, 2009
• 37 Shawker T H, Kluge R M, Ayella R J. Bacteremia associated with angiography.  JAMA. 1974;  229(8) 1090-1092
• 38 Meyer P, Reinzine D, Aymard A et al.. Septic complications in interventional radiology: evaluation of risk and preventive measures; Preliminary studies.  J Intervent Radiol. 1988;  3 73-75
• 39 Krupski W C, Pogany A, Effeney D J. Septic endarteritis after percutaneous transluminal angioplasty.  Surgery. 1985;  98(2) 359-362
• 40 Cooper J C, Woods D A, Spencer P, Procter A E. The development of an infected false aneurysm following iliac angioplasty.  Br J Radiol. 1991;  64(764) 759-760
• 41 Weinberg D J, Cronin D W, Baker Jr A G. Infected iliac pseudoaneurysm after uncomplicated percutaneous balloon angioplasty and (Palmaz) stent insertion: a case report and literature review.  J Vasc Surg. 1996;  23(1) 162-166
• 42 Calligaro K D, Veith F J, Yuan J G, Gargiulo N J, Dougherty M J. Intra-abdominal aortic graft infection: complete or partial graft preservation in patients at very high risk.  J Vasc Surg. 2003;  38(6) 1199-1205
• 43 Becker G J, Kovacs M, Mathison M N et al.. Risk stratification and outcomes of transluminal endografting for abdominal aortic aneurysm: 7-year experience and long-term follow-up.  J Vasc Interv Radiol. 2001;  12(9) 1033-1046
• 44 Fiorani P, Speziale F, Calisti A et al.. Endovascular graft infection: preliminary results of an international enquiry.  J Endovasc Ther. 2003;  10(5) 919-927
• 45 Sharif M A, Lee B, Lau L L et al.. Prosthetic stent graft infection after endovascular abdominal aortic aneurysm repair.  J Vasc Surg. 2007;  46(3) 442-448
• 46 Ryan J M, Ryan B M, Smith T P. Antibiotic prophylaxis in interventional radiology.  J Vasc Interv Radiol. 2004;  15(6) 547-556
• 47 Salman L, Asif A. Antibiotic prophylaxis: is it needed for dialysis access procedures?.  Semin Dial. 2009;  22(3) 297-299
• 48 Shah R, Mahour G H, Ford E G, Stanley P. Partial splenic embolization. An effective alternative to splenectomy for hypersplenism.  Am Surg. 1990;  56(12) 774-777
• 49 Amin M A, el-Gendy M M, Dawoud I E, Shoma A, Negm A M, Amer T A. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients.  World J Surg. 2009;  33(8) 1702-1710
• 50 Zhu K, Meng X, Qian J et al.. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.  Dig Liver Dis. 2009;  41(6) 411-416
• 51 Royal College of Obstetricians and Gynaecologists .Clinical recommendations on the use of uterine artery embolisation in the management of fibroids. Second edition June 2009. Available at: http://www.rcog.org.uk/womens-health/clinical-guidance/uterine-artery-embolisation-management-fibroids Accessed December 20, 2009
• 52 Ravina J H, Herbreteau D, Ciraru-Vigneron N et al.. Arterial embolisation to treat uterine myomata.  Lancet. 1995;  346(8976) 671-672
• 53 Nikolic B, Nguyen K, Martin L G, Redd D C, Best I, Silverstein M I. Pyosalpinx developing from a preexisting hydrosalpinx after uterine artery embolization.  J Vasc Interv Radiol. 2004;  15(3) 297-301
• 54 Walker W J, Pelage J P. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up.  BJOG. 2002;  109(11) 1262-1272
• 55 Pron G, Mocarski E, Cohen M et al.. Hysterectomy for complications after uterine artery embolization for leiomyoma: results of a Canadian multicenter clinical trial.  J Am Assoc Gynecol Laparosc. 2003;  10(1) 99-106
• 56 Vashisht A, Studd J, Carey A, Burn P. Fatal septicaemia after fibroid embolisation.  Lancet. 1999;  354(9175) 307-308
• 57 Mehta H, Sandhu C, Matson M, Belli A M. Review of readmissions due to complications from uterine fibroid embolization.  Clin Radiol. 2002;  57(12) 1122-1124
• 58 Rajan D K, Beecroft J R, Clark T WI et al.. Risk of intrauterine infectious complications after uterine artery embolization.  J Vasc Interv Radiol. 2004;  15(12) 1415-1421
• 59 Volkers N A, Hehenkamp W J, Smit P, Ankum W M, Reekers J A, Birnie E. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.  J Vasc Interv Radiol. 2008;  19(7) 1007-1016, quiz 1017
• 60 de Blok S, de Vries C, Prinssen H M, Blaauwgeers H LG, Jorna-Meijer L B. Fatal sepsis after uterine artery embolization with microspheres.  J Vasc Interv Radiol. 2003;  14(6) 779-783
• 61 Pelage J P, Jacob D, Le Dref O, Lacombe P, Laurent A. Re: fatal sepsis after uterine artery embolization with microspheres.  J Vasc Interv Radiol. 2004;  15(4) 405-406, author reply 406
• 62 Dutton S, Hirst A, McPherson K, Nicholson T, Maresh M A. A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium-term safety and efficacy.  BJOG. 2007;  114(11) 1340-1351
• 63 Freedman A M, Sanyal A J, Tisnado J et al.. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review.  Radiographics. 1993;  13(6) 1185-1210
• 64 DeSimone J A, Beavis K G, Eschelman D J, Henning K J. Sustained bacteremia associated with transjugular intrahepatic portosystemic shunt (TIPS).  Clin Infect Dis. 2000;  30(2) 384-386
• 65 Bouza E, Muñoz P, Rodríguez C et al.. Endotipsitis: an emerging prosthetic-related infection in patients with portal hypertension.  Diagn Microbiol Infect Dis. 2004;  49(2) 77-82
• 66 Sanyal A J, Reddy K R. Vegetative infection of transjugular intrahepatic portosystemic shunts.  Gastroenterology. 1998;  115(1) 110-115
• 67 Deibert P, Schwarz S, Olschewski M, Siegerstetter V, Blum H E, Rössle M. Risk factors and prevention of early infection after implantation or revision of transjugular intrahepatic portosystemic shunts: results of a randomized study.  Dig Dis Sci. 1998;  43(8) 1708-1713
• 68 Goldberg S N, Grassi C J, Cardella J F Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-guided Tumor Ablation et al. Image-guided tumor ablation: standardization of terminology and reporting criteria.  J Vasc Interv Radiol. 2009;  20(7, Suppl) S377-S390
• 69 Akahane M, Koga H, Kato N et al.. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management.  Radiographics. 2005;  25(Suppl 1) S57-S68
• 70 Rhim H, Yoon K H, Lee J M et al.. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings.  Radiographics. 2003;  23(1) 123-134 discussion 134-136
• 71 Livraghi T, Solbiati L, Meloni M F, Gazelle G S, Halpern E F, Goldberg S N. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.  Radiology. 2003;  226(2) 441-451
• 72 Shibata T, Yamamoto Y, Yamamoto N et al.. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors.  J Vasc Interv Radiol. 2003;  14(12) 1535-1542
• 73 Wah T M, Irving H C. Infectious complications after percutaneous radiofrequency ablation of renal cell carcinoma in patients with ileal conduit.  J Vasc Interv Radiol. 2008;  19(9) 1382-1385
• 74 de Baère T, Roche A, Amenabar J M et al.. Liver abscess formation after local treatment of liver tumors.  Hepatology. 1996;  23(6) 1436-1440
• 75 Xia J, Ren Z, Ye S et al.. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.  Eur J Radiol. 2006;  59(3) 407-412
• 76 Tarazov P G, Polysalov V N, Prozorovskij K V, Grishchenkova I V, Rozengauz E V. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies.  Acta Radiol. 2000;  41(2) 156-160
• 77 Chung J W, Park J H, Han J K et al.. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.  Radiology. 1996;  198(1) 33-40
• 78 Inoue H, Hori A, Satake M et al.. [Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS).  Nippon Igaku Hoshasen Gakkai Zasshi. 1992;  52(2) 155-163
• 79 Atassi B, Bangash A K, Lewandowski R J et al.. Biliary sequelae following radioembolization with Yttrium-90 microspheres.  J Vasc Interv Radiol. 2008;  19(5) 691-697
• 80 Chen C, Chen P J, Yang P M et al.. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma.  Am J Gastroenterol. 1997;  92(12) 2257-2259
• 81 Salem R, Thurston K G. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.  J Vasc Interv Radiol. 2006;  17(9) 1425-1439
• 82 Song S Y, Chung J W, Han J K et al.. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome.  J Vasc Interv Radiol. 2001;  12(3) 313-320
• 83 Chen S C, Tsai S J, Chen C H et al.. Predictors of mortality in patients with pyogenic liver abscess.  Neth J Med. 2008;  66(5) 196-203
• 84 Kim W, Clark T W, Baum R A, Soulen M C. Risk factors for liver abscess formation after hepatic chemoembolization.  J Vasc Interv Radiol. 2001;  12(8) 965-968
• 85 Duszak R. Percutaneous gastrostomy and jejunostomy. Available at: http://emedicine.medscape.com/article/421427-overview Accessed December 20, 2009
• 86 Gauderer M W, Ponsky J L, Izant Jr R J. Gastrostomy without laparotomy: a percutaneous endoscopic technique.  J Pediatr Surg. 1980;  15(6) 872-875
• 87 Wollman B, D'Agostino H B, Walus-Wigle J R, Easter D W, Beale A. Radiologic, endoscopic, and surgical gastrostomy: an institutional evaluation and meta-analysis of the literature.  Radiology. 1995;  197(3) 699-704
• 88 Friedman J N, Ahmed S, Connolly B, Chait P, Mahant S. Complications associated with image-guided gastrostomy and gastrojejunostomy tubes in children.  Pediatrics. 2004;  114(2) 458-461
• 89 Barron M A, Duncan D S, Green G J et al.. Efficacy and safety of radiologically placed gastrostomy tubes in paediatric haematology/oncology patients.  Med Pediatr Oncol. 2000;  34(3) 177-182
• 90 Hu H T, Shin J H, Song H Y et al.. Fluoroscopically guided percutaneous jejunostomy with use of a 21-gauge needle: a prospective study in 51 patients.  J Vasc Interv Radiol. 2009;  20(12) 1583-1587
• 91 Hallisey M J, Pollard J C. Direct percutaneous jejunostomy.  J Vasc Interv Radiol. 1994;  5(4) 625-632
• 92 Suzuki Y, Urashima M, Ishibashi Y et al.. Covering the percutaneous endoscopic gastrostomy (PEG) tube prevents peristomal infection.  World J Surg. 2006;  30(8) 1450-1458
• 93 Jain N K, Larson D E, Schroeder K W et al.. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial.  Ann Intern Med. 1987;  107(6) 824-828
• 94 Cantwell C P, Perumpillichira J J, Maher M M et al.. Antibiotic prophylaxis for percutaneous radiologic gastrostomy and gastrojejunostomy insertion in outpatients with head and neck cancer.  J Vasc Interv Radiol. 2008;  19(4) 571-575
• 95 Rosh A J, Manko J A. Cholangitis. Available at: http://emedicine.medscape.com/article/774245-overview Accessed December 20, 2009
• 96 Brody L A, Brown K T, Getrajdman G I et al.. Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage.  J Vasc Interv Radiol. 1998;  9(4) 572-578
• 97 Rösch T, Triptrap A, Born P et al.. Bacteriobilia in percutaneous transhepatic biliary drainage: occurrence over time and clinical sequelae. A prospective observational study.  Scand J Gastroenterol. 2003;  38(11) 1162-1168
• 98 Clark C D, Picus D, Dunagan W C. Bloodstream infections after interventional procedures in the biliary tract.  Radiology. 1994;  191(2) 495-499
• 99 Harris A, Chan A C, Torres-Viera C, Hammett R, Carr-Locke D. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP).  Endoscopy. 1999;  31(9) 718-724
• 100 Burke D R, Lewis C A, Cardella J F Society of Interventional Radiology Standards of Practice Committee et al. Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage.  J Vasc Interv Radiol. 2003;  14(9 Pt 2) S243-S246
• 101 Sheen-Chen S, Chen W, Eng H et al.. Bacteriology and antimicrobial choice in hepatolithiasis.  Am J Infect Control. 2000;  28(4) 298-301
• 102 Bishara J, Leibovici L, Huminer D et al.. Five-year prospective study of bacteraemic urinary tract infection in a single institution.  Eur J Clin Microbiol Infect Dis. 1997;  16(8) 563-567
• 103 Negrete-Pulido O, Gutierrez-Aceves J. Management of infectious complications in percutaneous nephrolithotomy.  J Endourol. 2009;  23(10) 1757-1762
• 104 Ramchandani P, Cardella J F, Grassi C J Society of Interventional Radiology Standards of Practice Committee et al. Quality improvement guidelines for percutaneous nephrostomy.  J Vasc Interv Radiol. 2003;  14(9 Pt 2) S277-S281
• 105 Gray R R, So C B, McLoughlin R F, Pugash R A, Saliken J C, Macklin N I. Outpatient percutaneous nephrostomy.  Radiology. 1996;  198(1) 85-88
• 106 Hausegger K A, Portugaller H R. Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications.  Eur Radiol. 2006;  16(9) 2016-2030
• 107 Carrafiello G, Laganà D, Mangini M et al.. Complications of percutaneous nephrostomy in the treatment of malignant ureteral obstructions: single-centre review.  Radiol Med (Torino). 2006;  111(4) 562-571
• 108 Lewis S, Patel U. Major complications after percutaneous nephrostomy-lessons from a department audit.  Clin Radiol. 2004;  59(2) 171-179
• 109 Smith T P, Ryan J M, Niklason L E. Sepsis in the interventional radiology patient.  J Vasc Interv Radiol. 2004;  15(4) 317-325
• 110 Ahluwalia R S, Johal N, Kouriefs C, Kooiman G, Montgomery B S, Plail R O. The surgical risk of suprapubic catheter insertion and long-term sequelae.  Ann R Coll Surg Engl. 2006;  88(2) 210-213
• 111 Cronan J J, Marcello A, Horn D L, Robinson A, Dorfman G S, Opal S. Antibiotics and nephrostomy tube care: preliminary observations. Part I. Bacteriuria.  Radiology. 1989;  172(3 Pt 2) 1041-1042
• 112 Thurmond A S, Rösch J. Nonsurgical fallopian tube recanalization for treatment of infertility.  Radiology. 1990;  174(2) 371-374
• 113 Hovsepian D M, Bonn J, Eschelman D J, Shapiro M J, Sullivan K L, Gardiner Jr G A. Fallopian tube recanalization in an unrestricted patient population.  Radiology. 1994;  190(1) 137-140
• 114 Pinto A BM, Hovsepian D M, Wattanakumtornkul S, Pilgram T K. Pregnancy outcomes after fallopian tube recanalization: oil-based versus water-soluble contrast agents.  J Vasc Interv Radiol. 2003;  14(1) 69-74
• 115 Puig J, Darnell A, Bermúdez P et al.. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?.  Eur Radiol. 2006;  16(4) 939-943
• 116 Sabbagh R, McCormack M, Péloquin F et al.. A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy.  Can J Urol. 2004;  11(2) 2216-2219
• 117 Argyropoulos A N, Doumas K, Farmakis A, Liakatas I, Gkialas I, Lykourinas M. Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy.  Int Urol Nephrol. 2007;  39(3) 897-903